Hong Kong leader Carrie Lam said Tuesday that the Asian financial hub will continue to implement a "zero dynamic" strategy to fight COVID-19. Hong Kong is currently facing its biggest test of controlling a record infection rate.
The Organizing Committee for the Beijing 2022 Winter Olympics said on Tuesday (8/2/2022) that six new cases of COVID-19 were found among Olympic personnel as of February 7.
The number of people hospitalized and admitted to intensive care due to COVID-19 in Australia continued to decline on Tuesday (8/2/2022). Authorities urged the public to get booster doses of the vaccine to prevent severe illness and death.
New Zealand Prime Minister Jacinda Ardern said the COVID-19 pandemic would not end with the Omicron variant. New Zealand must prepare for more variants of the coronavirus this year.
Botswana's budget deficit has increased to 5.1 percent of Gross Domestic Product (GDP). The country is spending funds to finance its recovery from the COVID-19 pandemic.
Nigeria has received 2 million doses of Johnson & Johnson's vaccine from Finland, Greece and Slovenia. Additional vaccine donations from the European Union are expected in the coming weeks, government officials said.
The US Centers for Disease Control and Prevention advises US citizens to avoid travel to six countries: Japan, Cuba, Libya, Armenia, Oman and the Democratic Republic of the Congo.
Mexico's health minister reported 9,242 new cases of COVID-19 and 206 deaths on Monday (7/2/2022). The total number of cases in the country since the start of the pandemic stands at 5,160,767 with 309,000 more deaths.
Sweden has decided to lift the COVID-19 restrictions for foreign nationals visiting the country from Nordic countries and other member states of the European Union and European Economic Area (EEA) from Wednesday (9/2/2022).
Several German states are planning to relax COVID-19 restrictions despite the rising number of infections.
Novavax Inc said Monday that US government funding for the company's vaccine has been increased to include final-stage research into booster doses for adolescents.
Until Friday, February 11, 2022, the Covid-19 antibody drug which is believed to be effective against the Omicron variant, namely Sotrovimab from Vir Biotechnology and GSK. But a study suggests that the drug is unlikely to work well against at least one new version of the variant that is spreading globally.
This antibody drug, which has been approved by the US Food and Drug Administration, showed promise when tested against the "sublineage," or subvariant of Omicron.